Clinical Trial Update: Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the inhaled combination of salmeterol and fluticasone for bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Salmeterol/Fluticasone (fluticasone propionate/salmeterol)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Bronchiectasis | Phase 4 | Status: COMPLETED